NGM logo

NGM Biopharmaceuticals (NGM) EBITDA

Annual EBITDA

-$149.24 M
+$12.97 M+8.00%

December 31, 2023

Summary

Performance

1-Year Change

+8%

3-Year Change

-53.42%

5-Year Change

-5230.35%

15-Year Change

-1258.72%

NGM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.91 M
NGM annual EBITDA is currently -5230.35% below its historical high of $2.91 million

3-Year Low

-$162.21 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NGM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
NGM next annual earnings announcement has not yet been scheduled

OtherNGMprofitabilitymetrics:

Annual Revenue

$4.42 M
NGM annual revenue is $4.42 million

Annual Net Income

-$142.38 M
NGM annual net profit is -$142.38 million

Annual EBIT

-$151.46 M
NGM annual earnings before interest & taxes is -$151.46 million

Annual EPS

-$1.73
NGM annual earnings per share is -$1.73

Quarterly EBITDA

-$29.14 M
+$1.35 M+4.43%

December 31, 2023

Summary

Performance

3-Month Change

+4.43%

1-Year Change

+41.22%

3-Year Change

-11.58%

5-Year Change

-294.99%

NGM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.95 M
NGM quarterly EBITDA is currently -294.99% below its historical high of $14.95 million

3-Year Low

-$49.59 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NGM previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
NGM next earnings announcement has not yet been scheduled

OtherNGMprofitabilitymetrics:

Quarterly Revenue

$165.00 K
NGM quarterly revenue is $165.00 thousand

Quarterly Net Income

-$27.67 M
NGM quarterly net profit is -$27.67 million

Quarterly EBIT

-$29.66 M
NGM quarterly earnings before interest & taxes is -$29.66 million

Quarterly EPS

-$0.34
NGM quarterly earnings per share is -$0.34

TTM EBITDA

-$149.24 M
+$8.54 M+5.41%

December 31, 2023

Summary

Performance

3-Month Change

+5.41%

1-Year Change

+17.38%

3-Year Change

-53.42%

5-Year Change

-257.59%

NGM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$2.91 M
NGM TTM EBITDA is currently -5230.35% below its historical high of $2.91 million

3-Year Low

-$180.65 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
NGM previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
NGM next earnings announcement has not yet been scheduled

OtherNGMprofitabilitymetrics:

TTM Revenue

$4.42 M
NGM TTM revenue is $4.42 million

TTM Net Income

-$142.38 M
NGM TTM net profit is -$142.38 million

TTM EBIT

-$151.46 M
NGM TTM earnings before interest & taxes is -$151.46 million

TTM EPS

-$1.73
NGM TTM earnings per share is -$1.73

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$149.24 M
NGM annual EBITDA is -$149.24 million

Annual Net Income

-$142.38 M
NGM annual net profit is -$142.38 million

Annual Interest Expense

-
NGM annual interest expense value is unknown

Annual Income Tax

-
NGM annual income tax value is unknown

Annual D&A

$2.22 M
NGM annual depreciation & amortization is $2.22 million

NGM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.0%+41.2%+17.4%
3 y3 years-53.4%-11.6%-53.4%
5 y5 years-5230.4%-295.0%-257.6%

NGM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+30.2%+8.7%+13.2%+70.1%+30.2%+21.0%
5 y5-year+257.6%+8.7%+87.7%+70.1%+257.6%+21.0%
alltimeall time-5230.4%+8.7%-295.0%+70.1%-5230.4%+21.0%

NGM Biopharmaceuticals EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$149.24 M(-8.0%)
-$29.14 M(-4.4%)
-$149.24 M(-5.4%)
Sep 2023
-
-$30.50 M(-23.8%)
-$157.78 M(-9.8%)
Jun 2023
-
-$40.02 M(-19.3%)
-$174.99 M(-3.1%)
Mar 2023
-
-$49.59 M(+31.6%)
-$180.65 M(+11.4%)
Dec 2022
-$162.21 M(+41.5%)
-$37.68 M(-21.0%)
-$162.21 M(+7.9%)
Sep 2022
-
-$47.71 M(+4.5%)
-$150.28 M(+15.5%)
Jun 2022
-
-$45.67 M(+46.6%)
-$130.08 M(+8.9%)
Mar 2022
-
-$31.15 M(+21.0%)
-$119.47 M(+4.2%)
Dec 2021
-$114.61 M(+17.8%)
-$25.75 M(-6.4%)
-$114.61 M(-0.3%)
Sep 2021
-
-$27.51 M(-21.5%)
-$114.98 M(-0.7%)
Jun 2021
-
-$35.06 M(+33.3%)
-$115.80 M(+10.7%)
Mar 2021
-
-$26.29 M(+0.7%)
-$104.63 M(+7.6%)
Dec 2020
-$97.28 M
-$26.12 M(-7.8%)
-$97.28 M(+12.2%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$28.34 M(+18.6%)
-$86.69 M(+24.9%)
Jun 2020
-
-$23.88 M(+26.1%)
-$69.40 M(+30.2%)
Mar 2020
-
-$18.94 M(+22.0%)
-$53.29 M(+27.7%)
Dec 2019
-$41.73 M(-1534.7%)
-$15.53 M(+40.5%)
-$41.73 M(+270.6%)
Sep 2019
-
-$11.05 M(+42.2%)
-$11.26 M(+65.7%)
Jun 2019
-
-$7.77 M(+5.3%)
-$6.80 M(+353.1%)
Mar 2019
-
-$7.38 M(-149.4%)
-$1.50 M(-151.6%)
Dec 2018
$2.91 M(-126.5%)
$14.95 M(-326.8%)
$2.91 M(-124.2%)
Sep 2018
-
-$6.59 M(+166.2%)
-$12.04 M(+121.0%)
Jun 2018
-
-$2.48 M(-16.7%)
-$5.45 M(+83.3%)
Mar 2018
-
-$2.97 M
-$2.97 M
Dec 2017
-$10.98 M(+127.6%)
-
-
Dec 2016
-$4.83 M
-
-

FAQ

  • What is NGM Biopharmaceuticals annual EBITDA?
  • What is the all time high annual EBITDA for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals annual EBITDA year-on-year change?
  • What is NGM Biopharmaceuticals quarterly EBITDA?
  • What is the all time high quarterly EBITDA for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals quarterly EBITDA year-on-year change?
  • What is NGM Biopharmaceuticals TTM EBITDA?
  • What is the all time high TTM EBITDA for NGM Biopharmaceuticals?
  • What is NGM Biopharmaceuticals TTM EBITDA year-on-year change?

What is NGM Biopharmaceuticals annual EBITDA?

The current annual EBITDA of NGM is -$149.24 M

What is the all time high annual EBITDA for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high annual EBITDA is $2.91 M

What is NGM Biopharmaceuticals annual EBITDA year-on-year change?

Over the past year, NGM annual EBITDA has changed by +$12.97 M (+8.00%)

What is NGM Biopharmaceuticals quarterly EBITDA?

The current quarterly EBITDA of NGM is -$29.14 M

What is the all time high quarterly EBITDA for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high quarterly EBITDA is $14.95 M

What is NGM Biopharmaceuticals quarterly EBITDA year-on-year change?

Over the past year, NGM quarterly EBITDA has changed by +$20.44 M (+41.22%)

What is NGM Biopharmaceuticals TTM EBITDA?

The current TTM EBITDA of NGM is -$149.24 M

What is the all time high TTM EBITDA for NGM Biopharmaceuticals?

NGM Biopharmaceuticals all-time high TTM EBITDA is $2.91 M

What is NGM Biopharmaceuticals TTM EBITDA year-on-year change?

Over the past year, NGM TTM EBITDA has changed by +$31.40 M (+17.38%)